guidelines:
  1: R-ISS_guideline.v1
test_cases:
- id: R-ISS I
  input:
    1:
      gt0005|Serum β2 microglobulin: 1|local::at0005|<3.5 mg/L|
      gt0006|Serum albumin: 2|local::at0010|≥3.5 g/dL|
      gt0007|CA by iFISH: 1|local::at0012|Standard risk|
      gt0008|LDH: 1|local::at0015|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0029|R-ISS Stage I|
      gt0011|Median progression-free survival: local::at0024|66 months median progression-free survival|
      gt0015|ISS stage: local::at0032|ISS I|
- id: R-ISS II case 1
  input:
    1:
      gt0005|Serum β2 microglobulin: 1|local::at0005|<3.5 mg/L|
      gt0006|Serum albumin: 2|local::at0010|≥3.5 g/dL|
      gt0007|CA by iFISH: 2|local::at0013|High risk|
      gt0008|LDH: 1|local::at0015|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0011|Median progression-free survival: local::at0023|42 months median progression-free survival|
      gt0015|ISS stage: local::at0032|ISS I|
- id: R-ISS II case 2
  input:
    1:
      gt0005|Serum β2 microglobulin: 1|local::at0005|<3.5 mg/L|
      gt0006|Serum albumin: 1|local::at0009|<3.5 g/dL|
      gt0007|CA by iFISH: 1|local::at0012|Standard risk|
      gt0008|LDH: 2|local::at0016|High (> upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0011|Median progression-free survival: local::at0023|42 months median progression-free survival|
      gt0015|ISS stage: local::at0033|ISS II|
- id: R-ISS II case 3
  input:
    1:
      gt0005|Serum β2 microglobulin: 1|local::at0005|<3.5 mg/L|
      gt0006|Serum albumin: 1|local::at0009|<3.5 g/dL|
      gt0007|CA by iFISH: 2|local::at0013|High risk|
      gt0008|LDH: 2|local::at0016|High (> upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0011|Median progression-free survival: local::at0023|42 months median progression-free survival|
      gt0015|ISS stage: local::at0033|ISS II|
- id: R-ISS II case 4
  input:
    1:
      gt0005|Serum β2 microglobulin: 2|local::at0006|3.5-5.4 mg/L|
      gt0006|Serum albumin: 1|local::at0009|<3.5 g/dL|
      gt0007|CA by iFISH: 2|local::at0013|High risk|
      gt0008|LDH: 2|local::at0016|High (> upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0011|Median progression-free survival: local::at0023|42 months median progression-free survival|
      gt0015|ISS stage: local::at0033|ISS II|
- id: R-ISS II case 5
  input:
    1:
      gt0005|Serum β2 microglobulin: 2|local::at0006|3.5-5.4 mg/L|
      gt0006|Serum albumin: 1|local::at0009|<3.5 g/dL|
      gt0007|CA by iFISH: 2|local::at0013|High risk|
      gt0008|LDH: 1|local::at0015|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0011|Median progression-free survival: local::at0023|42 months median progression-free survival|
      gt0015|ISS stage: local::at0033|ISS II|
- id: R-ISS II case 6
  input:
    1:
      gt0005|Serum β2 microglobulin: 2|local::at0006|3.5-5.4 mg/L|
      gt0006|Serum albumin: 1|local::at0009|<3.5 g/dL|
      gt0007|CA by iFISH: 1|local::at0012|Standard risk|
      gt0008|LDH: 1|local::at0015|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0011|Median progression-free survival: local::at0023|42 months median progression-free survival|
      gt0015|ISS stage: local::at0033|ISS II|
- id: R-ISS II case 7
  input:
    1:
      gt0005|Serum β2 microglobulin: 3|local::at0007|>5.4 mg/L|
      gt0006|Serum albumin: 1|local::at0009|<3.5 g/dL|
      gt0007|CA by iFISH: 1|local::at0012|Standard risk|
      gt0008|LDH: 1|local::at0015|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0011|Median progression-free survival: local::at0023|42 months median progression-free survival|
      gt0015|ISS stage: local::at0034|ISS III|
- id: R-ISS III case 1
  input:
    1:
      gt0005|Serum β2 microglobulin: 3|local::at0007|>5.4 mg/L|
      gt0006|Serum albumin: 2|local::at0010|≥3.5 g/dL|
      gt0007|CA by iFISH: 1|local::at0012|Standard risk|
      gt0008|LDH: 2|local::at0016|High (> upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0031|R-ISS Stage III|
      gt0011|Median progression-free survival: local::at0022|29 months median progression-free survival|
      gt0015|ISS stage: local::at0034|ISS III|
- id: R-ISS III case 2
  input:
    1:
      gt0005|Serum β2 microglobulin: 3|local::at0007|>5.4 mg/L|
      gt0006|Serum albumin: 2|local::at0010|≥3.5 g/dL|
      gt0007|CA by iFISH: 2|local::at0013|High risk|
      gt0008|LDH: 2|local::at0016|High (> upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0031|R-ISS Stage III|
      gt0011|Median progression-free survival: local::at0022|29 months median progression-free survival|
      gt0015|ISS stage: local::at0034|ISS III|
- id: R-ISS III case 3
  input:
    1:
      gt0005|Serum β2 microglobulin: 3|local::at0007|>5.4 mg/L|
      gt0006|Serum albumin: 2|local::at0010|≥3.5 g/dL|
      gt0007|CA by iFISH: 2|local::at0013|High risk|
      gt0008|LDH: 1|local::at0015|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0012|R-ISS Stage: local::at0031|R-ISS Stage III|
      gt0011|Median progression-free survival: local::at0022|29 months median progression-free survival|
      gt0015|ISS stage: local::at0034|ISS III|
